Beranda › Kardiomiopati Hipertrofik › Massachusetts
Uji klinis Kardiomiopati Hipertrofik di Massachusetts
6 studi untuk Kardiomiopati Hipertrofik mencari peserta di lokasi di Massachusetts.
Kota di Massachusetts
Teks studi resmi (Bahasa Inggris)
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
- Harvard (Massachusetts General Hospital), Boston
- Harvard Medical School - Brigham and Women's Hospital (BWH), Boston
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 19 Agu 2026 · NCT05489705Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis
- Tufts Medical Center, Boston
- Boston Medical Center, Boston
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 50 ke atas · Semua jenis kelamin · Diperbarui 4 Jun 2026 · NCT06034405A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy
- Imbria Investigational Site, Boston
- Imbria Investigational Site, Burlington
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Mei 2026 · NCT07023614A Gene Therapy Study of RP-A501 in Male Patients With Danon Disease
- Boston Children's Hospital, Boston
Menerima pesertaFase 2
Usia 8 ke atas · Pria · Diperbarui 4 Mei 2026 · NCT06092034HCMR Re-Imaging Study
- Brigham & Women's Hospital, Boston
- Tufts Medical Center, Medford
Menerima pesertaStudi observasional
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 18 Mar 2026 · NCT07054073Real-world Patient Reported Outcomes Among Patients Treated With Camzyos
- Analysis Group Inc., Boston
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 7 Nov 2024 · NCT06551129Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.